Identification and Characterization of New Alu Element Insertion in the BRCA1 Exon 14 Associated with Hereditary Breast and Ovarian Cancer
Open Access
Abstract
Hereditary breast and ovarian cancer syndrome (HBOC) is an autosomal dominant cancer predisposition syndrome characterized by an increased risk of breast and ovarian cancers. Germline pathogenic variants in BRCA1 are found in about 7–10% of all familial breast cancers and 10% of ovarian cancers. Alu elements are the most abundant mobile DNA element in the human genome and are known to affect the human genome by different mechanisms leading to human disease. We report here the detection, by next-generation sequencing (NGS) analysis coupled with a suitable bioinformatics pipeline, of an AluYb8 element in exon 14 of the BRCA1 gene in a family with HBOC history first classified as BRCA-negative by Sanger sequencing and first NGS analysis. The c.4475_c.4476insAluYb8 mutation impacts splicing and induces the skipping of exon 14. As a result, the produced mRNA contains a premature stop, leading to the production of a short and likely non-functional protein (pAla1453Glyfs*10). Overall, our study allowed us to identify a novel pathogenic variant in BRCA1 and showed the importance of bioinformatics tool improvement and versioning.Keywords
This publication has 17 references indexed in Scilit:
- Detecting splicing patterns in genes involved in hereditary breast and ovarian cancerEuropean Journal of Human Genetics, 2017
- LoRTE: Detecting transposon-induced genomic variants using low coverage PacBio long read sequencesMobile DNA, 2017
- The Dfam database of repetitive DNA familiesNucleic Acids Research, 2015
- Hereditary breast and ovarian cancer susceptibility genes (Review)Oncology Reports, 2013
- Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variantsHuman Mutation, 2012
- Familial Breast CancerClinical Genetics, 2012
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutationBreast Cancer Research and Treatment, 2010
- The impact of retrotransposons on human genome evolutionNature Reviews Genetics, 2009
- The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central PortugalBreast Cancer Research and Treatment, 2008